The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Genetics of the neuronal ceroid lipofuscinoses (Batten disease)
Open accessAbstract
The neuronal ceroid lipofuscinoses (NCLs) are a group of inherited neurodegenerative disorders that affect children and adults, and are grouped together by similar clinical features and the accumulation of autofluorescent storage material. More than a dozen genes containing over 430 mutations underlying human NCLs have been identified. These genes encode lysosomal enzymes (CLN1, CLN2, CLN10, CLN13), a soluble lysosomal protein (CLN5), a protein in the secretory pathway (CLN11), two cytoplasmic proteins that also peripherally associate with membranes (CLN4, CLN14), and many transmembrane proteins with different subcellular locations (CLN3, CLN6, CLN7, CLN8, CLN12). For most NCLs, the function of the causative gene has not been fully defined. Most of the mutations in these genes are associated with a typical disease phenotype, but some result in variable disease onset, severity and progression, including distinct clinical phenotypes. There remain disease subgroups with unknown molecular genetic backgrounds. This article is part of a Special Issue entitled: The Neuronal Ceroid Lipofuscinoses or Batten Disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq929 · Cited by 2,278
Vesa, J., Hellsten, E., Verkruyse, L. A., Camp, L. A., Rapola, J., Santavuori, P., Hofmann, S. L., & Peltonen, L. (1995) · Nature · doi:10.1038/376584a0 · Cited by 737
Isolation of a novel gene underlying batten disease, CLN3
Lerner, T. J., Boustany, R.-M. N., Anderson, J. W., D'Arigo, K. L., Schlumpf, K., Buckler, A. J., Gusella, J. F., & Haines, J. L. (1995) · Cell · doi:10.1016/0092-8674(95)90274-0 · Cited by 601
Mutations in the Glucocerebrosidase Gene and Parkinson's Disease in Ashkenazi Jews
Aharon-Peretz, J., Rosenbaum, H., & Gershoni-Baruch, R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033277 · Cited by 597
Sleat, D. E., Donnelly, R. J., Lackland, H., Liu, C.-G., Sohar, I., Pullarkat, R. K., & Lobel, P. (1997) · Science · doi:10.1126/science.277.5333.1802 · Cited by 581
Strikingly Different Clinicopathological Phenotypes Determined by Progranulin-Mutation Dosage
Smith, K. R., Damiano, J., Franceschetti, S., Carpenter, S., Canafoglia, L., Morbin, M., Rossi, G., Pareyson, D., Mole, S. E., Staropoli, J. F., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.04.021 · Cited by 489
Self-citationCathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis
Siintola, E. (2006) · Brain · doi:10.1093/brain/awl107 · Cited by 389
Kousi, M., Lehesjoki, A.-E., & Mole, S. E. (2012) · Human Mutation · doi:10.1002/humu.21624 · Cited by 332
Self-citationRanta, S., Zhang, Y., Ross, B., Lonka, L., Takkunen, E., Messer, A., Sharp, J., Wheeler, R., Kusumi, K., Mole, S., et al. (1999) · Nature Genetics · doi:10.1038/13868 · Cited by 319
Self-citationMole, S. E., Williams, R. E., & Goebel, H. H. (2005) · Neurogenetics · doi:10.1007/s10048-005-0218-3 · Cited by 307
Self-citationSavukoski, M., Klockars, T., Holmberg, V., Santavuori, P., Lander, E. S., & Peltonen, L. (1998) · Nature Genetics · doi:10.1038/975 · Cited by 302
Cathepsin D Deficiency Is Associated with a Human Neurodegenerative Disorder
Steinfeld, R., Reinhardt, K., Schreiber, K., Hillebrand, M., Kraetzner, R., Brück, W., Saftig, P., & Gärtner, J. (2006) · The American Journal of Human Genetics · doi:10.1086/504159 · Cited by 302
Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis
Bras, J., Verloes, A., Schneider, S. A., Mole, S. E., & Guerreiro, R. J. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds089 · Cited by 266
Self-citationNosková, L., Stránecký, V., Hartmannová, H., Přistoupilová, A., Barešová, V., Ivánek, R., Hůlková, H., Jahnová, H., van der Zee, J., Staropoli, J. F., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.07.003 · Cited by 261
Self-citationWang, F., Wang, H., Tuan, H.-F., Nguyen, D. H., Sun, V., Keser, V., Bowne, S. J., Sullivan, L. S., Luo, H., Zhao, L., et al. (2014) · Human Genetics · doi:10.1007/s00439-013-1381-5 · Cited by 244
New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses
Williams, R. E., & Mole, S. E. (2012) · Neurology · doi:10.1212/wnl.0b013e31825f0547 · Cited by 232
Self-citationThe Novel Neuronal Ceroid Lipofuscinosis Gene MFSD8 Encodes a Putative Lysosomal Transporter
Siintola, E., Topcu, M., Aula, N., Lohi, H., Minassian, B. A., Paterson, A. D., Liu, X.-Q., Wilson, C., Lahtinen, U., Anttonen, A.-K., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/518902 · Cited by 229
Wheeler, R. B., Sharp, J. D., Schultz, R. A., Joslin, J. M., Williams, R. E., & Mole, S. E. (2002) · The American Journal of Human Genetics · doi:10.1086/338708 · Cited by 199
Self-citationCell biology of the NCL proteins: What they do and don't do
Cárcel-Trullols, J., Kovács, A. D., & Pearce, D. A. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.04.027 · Cited by 176
Kufs Disease, the Major Adult Form of Neuronal Ceroid Lipofuscinosis, Caused by Mutations in CLN6
Arsov, T., Smith, K. R., Damiano, J., Franceschetti, S., Canafoglia, L., Bromhead, C. J., Andermann, E., Vears, D. F., Cossette, P., Rajagopalan, S., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.04.004 · Cited by 164
Self-citationProgranulin is expressed within motor neurons and promotes neuronal cell survival
Ryan, C. L., Baranowski, D. C., Chitramuthu, B. P., Malik, S., Li, Z., Cao, M., Minotti, S., Durham, H. D., Kay, D. G., Shaw, C. A., et al. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-130 · Cited by 160
Cathepsin F mutations cause Type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosis
Smith, K. R., Dahl, H.-H. M., Canafoglia, L., Andermann, E., Damiano, J., Morbin, M., Bruni, A. C., Giaccone, G., Cossette, P., Saftig, P., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds558 · Cited by 130
Self-citationMutation of a potassium channel–related gene in progressive myoclonic epilepsy
Bogaert, P. V., Azizieh, R., Désir, J., Aeby, A., Meırleır, L. D., Laes, J., Christiaens, F. J. C., & Abramowicz, M. J. (2007) · Annals of Neurology · doi:10.1002/ana.21121 · Cited by 119
Staropoli, J. F., Karaa, A., Lim, E. T., Kirby, A. W., Elbalalesy, N., Romansky, S. G., Leydiker, K., Coppel, S., Barone, R., Xin, W. W., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.05.023 · Cited by 115
Self-citationSun, Y., Almomani, R., Breedveld, G. J., Santen, G. W. E., Aten, E., Lefeber, D. J., Hoff, J. I., Brusse, E., Verheijen, F. W., Verdijk, R. M., et al. (2013) · Human Mutation · doi:10.1002/humu.22292 · Cited by 90
Kitzmüller, C., Haines, R. L., Codlin, S., Cutler, D. F., & Mole, S. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm306 · Cited by 88
Self-citationRoosing, S., van den Born, L. I., Sangermano, R., Banfi, S., Koenekoop, R. K., Zonneveld-Vrieling, M. N., Klaver, C. C. W., van Lith-Verhoeven, J. J. C., Cremers, F. P. M., den Hollander, A. I., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.07.040 · Cited by 81
Impaired cell adhesion and apoptosis in a novel CLN9 Batten disease variant
Schulz, A., Dhar, S., Rylova, S. N., Dbaibo, G. S., Alroy, J., Hagel, C., Artacho, I., Kohlschütter, A., Lin, S. M., & Boustany, R. (2004) · Annals of Neurology · doi:10.1002/ana.20187 · Cited by 79
Novel mutations consolidate KCTD7 as a progressive myoclonus epilepsy gene
Kousi, M., Anttila, V., Schulz, A., Calafato, S., Jakkula, E., Riesch, E., Myllykangas, L., Kalimo, H., Topçu, M., Gökben, S., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-100859 · Cited by 79
Vantaggiato, C., Redaelli, F. C., Falcone, S., Perrotta, C., Tonelli, A., Bondioni, S., Morbin, M., Riva, D., Saletti, V., Bonaglia, M. C., et al. (2009) · Human Mutation · doi:10.1002/humu.21012 · Cited by 61
Zhang, H., Stein, P., Liu, J., Wang, Z., Yang, R., Cho, J. H., Gregersen, P. K., Aerts, J. M. F. G., Zhao, H., Pastores, G. M., et al. (2012) · American Journal of Hematology · doi:10.1002/ajh.23118 · Cited by 60
CLN 5 and CLN 8 protein association with ceramide synthase: B iochemical and proteomic approaches
Haddad, S. E., Khoury, M., Daoud, M., Kantar, R. S., Harati, H., Mousallem, T. I., Álzate, Ó., Meyer, B. F., & Boustany, R. (2012) · Electrophoresis · doi:10.1002/elps.201200472 · Cited by 60
Blumkin, L., Kivity, S., Lev, D., et al. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6545-z · Cited by 59
Sleat, D. E., Ding, L., Wang, S., Zhao, C., Wang, Y., Xin, W. W., Zheng, H., Moore, D. F., & Sims, K. B. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900122-mcp200 · Cited by 53
Sartelet, A., Stauber, T., Coppieters, W., Ludwig, C. F., Fasquelle, C., Druet, T., Zhang, Z.-Y., Ahariz, N., Cambisano, N., Jentsch, T., et al. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.012500 · Cited by 48
Novel CLN3 mutation causing autophagic vacuolar myopathy
Cortese, A., Tucci, A., Piccolo, G., Galimberti, C. A., Fratta, P., Marchioni, E., Grampa, G., Cereda, C., Grieco, G. S., Ricca, I., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000490 · Cited by 46
Self-citationExperimental therapies in the neuronal ceroid lipofuscinoses
Neverman, N. J., Best, H. L., Hofmann, S. L., & Hughes, S. M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.04.026 · Cited by 35
Erickson, R. P., Larson‐Thomé, K., Weberg, L., Szybińska, A., Mossakowska, M., Styczyńska, M., Barcikowska, M., & Kuźnicki, J. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.09.046 · Cited by 33
Staropoli, J. F., Xin, W. W., Barone, R., Cotman, S. L., & Sims, K. B. (2012) · BMC Medical Genetics · doi:10.1186/1471-2350-13-50 · Cited by 19
Self-citation
Cited by
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
Kim, J., Hu, C., Moufawad El Achkar, C., Black, L. E., Douville, J., Larson, A., Pendergast, M. K., Goldkind, S. F., Lee, E. A., Kuniholm, A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1813279 · Cited by 827
The lysosomal function of progranulin, a guardian against neurodegeneration
Paushter, D. H., Du, H., Feng, T., & Hu, F. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1861-8 · Cited by 230
Lysosome biogenesis in health and disease
Bajaj, L., Lotfi, P., Pal, R., Ronza, A. D., Sharma, J., & Sardiello, M. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14564 · Cited by 153
The Batten disease gene product CLN5 is the lysosomal bis(monoacylglycero)phosphate synthase
Medoh, U. N., Hims, A., Chen, J. Y., Ghoochani, A., Nyame, K., Dong, W., & Abu-Remaileh, M. (2023) · Science · doi:10.1126/science.adg9288 · Cited by 87
Pathomechanisms in the neuronal ceroid lipofuscinoses
Nelvagal, H. R., Lange, J., Takahashi, K., Tarczyluk-Wells, M. A., & Cooper, J. D. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165570 · Cited by 80
Metadata
- Authors
- Mole, S. E., & Cotman, S. L.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2015-10
- Volume
- 1852
- Issue
- 10
- Pages
- 2237-2241
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W430977535
- Cited by
- 331
- References
- 39
- FWCI
- 18.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.